NXChain Inc. Acquires  NXChain Inc. (OTCQB: NXCN), a fully reporting Shell Company traded on OTCMarkets ("NXCN"), today announced its entry into a binding contract to acquire 49.9 percent of ExPay Asia, a privately-

NXChain Inc. Acquires 49.9 Percent of ExPay Payment Platform in Asia

Facilitating Broad Integration of Digital Currency in the Digital Payments Markets

NXChain Inc. Acquires  NXChain Inc. (OTCQB: NXCN), a fully reporting Shell Company traded on OTCMarkets ("NXCN"), today announced its entry into a binding contract to acquire 49.9 percent of ExPay Asia, a privately-

FOREX INVESTORS BUZZ   PRESS RELEASE  NXChain Inc. Acquires  NXChain Inc. (OTCQB: NXCN), a fully reporting Shell Company traded on OTCMarkets (“NXCN”), today announced its entry into a binding contract to acquire 49.9 percent of ExPay Asia, a privately-held payments company operating in the Asian market. The companies will work together to implement future payment solutions based on the digital assets platform developed by NXCN. NXCN has previously completed the purchase of digital currency backbone technologies from LXCCoin Ltd. UK, and this is an important step for the upcoming launch of services for the company. NXCN has been operating in stealth and will continue to do so for some time yet.

Foreign ownership is restricted in Thailand, and NXCN has requested regulatory clearances from BOI in regards to its foreign ownership. Once permission is granted NXCN may execute an option it is currently holding for a 51 percent majority ownership.



NXChain Inc. Acquires

 

About ExPay Asia

The ExPay Group was formed in 2012 by finance industry executives to develop an open platform for online merchants incorporating intelligent back office solutions. The company has grown steadily and is currently turning over an approximate $40 million annually with a net result of $1.25 million. The company focuses on combining a range of innovative services to existing payment solutions and has through the partnership with NXCN already secured new business, aiming at doubling both turnover and result next year. More information can be found at http://expay.asia.

About NxChain, Inc.

NxChain, Inc. is a fully reporting and trading Company on OTCMarkets under the trading symbol NXCN.QB. The Company is growing its business through acquisitions and mergers of cryptocurrency companies and technologies to provide a fixed-price cryptocurrency platform to multiple levels of the financial industry in various markets worldwide. More information can be found at http://www.nxchain.com.

NXCN and ExPay are working jointly on constructing a digital currency gateway combining several technologies, including amongst others the NXCN-owned LXCCoin Digital Currency backbone.

Mr. Sean Tabatabai, CEO of NXChain comments: “We firmly believe that our platform of blockchain technology will induce a paradigm shift in the way we do transactions. Our team has worked on our platform extensively for years, and at present we are including certain other technologies to work in concert with our services. We have great faith in ExPay being a key component in our future business.”

Mr. Chakrit Ahmad, CEO of ExPay comments: “We expect blockchain to become a core of future money transactions, but until we started testing with NXCN and their stable currencies we did not see how volatile and/or slowly transacting digital currencies could be integrated into what we are doing. While still focusing on current business; we anticipate that being part of the NXCN technology platform presents some unique advantages and we look forward with excitement to releasing services together.”

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

Market Quotes by TradingView

Like up on FACEBOOK


logo



MassRoots, Inc. (MSRT) Acquires Odava

MassRoots Acquires Odava, a Leading Compliance Platform for the Cannabis Industry

The combination of the two companies is expected to create one of the largest technology conglomerates in the cannabis market

MassRoots, Inc. <span data-recalc-dims=(MSRT) and Odava, Inc., a leading regulatory compliance platform for the cannabis industry, have executed a Definitive " width="300" height="141" srcset="https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/04/massroots5-1.jpg?resize=300%2C141 300w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/04/massroots5-1.jpg?w=700 700w" sizes="(max-width: 300px) 100vw, 300px" />

FOREX INVESTORS  PRESS RELEASE   MassRoots, Inc. (MSRT) and Odava, Inc., a leading regulatory compliance platform for the cannabis industry, have executed a Definitive Agreement for MassRoots to acquire Odava for cash and shares of MassRoots’ common stock. Odava is an industry-leading platform technology that provides compliance, point-of-sale, and supply chain management for the cannabis industry. The closing of the acquisition is subject to certain closing conditions as detailed in MassRoots’ Current Report on Form 8-K.

Through its point-of-sale and regulatory compliance system, Odava automates and streamlines business operations for cannabis dispensaries and cultivators. Since launching in beta of June 2016, Odava has been able to secure dozens of medical and recreational dispensary customers in the Oregon market.




MassRoots, Inc

 

The combination of the two companies is expected to create one of the largest technology conglomerates in the cannabis market and now will also be providing regulatory compliance, point-of-sale and consumer engagement programs for the entire industry.

“This acquisition expands MassRoots’ offerings to dispensaries to include point-of-sale and regulatory compliance software, consolidating the most important operations for cannabis businesses into one central platform,” stated MassRoots CEO Mr. Isaac Dietrich. “We expect with MassRoots’ resources and relationships, we can grow the number of dispensaries utilizing Odava from dozens to hundreds by early next year. In the near future, we believe a significant percentage of all transactions occurring in the regulated cannabis industry will occur on our platform.”

Currently, Odava offers end-to-end regulatory compliance and point-of-sale software to dispensaries and cultivators in Oregon. MassRoots plans to expand Odava’s availability to the California, Nevada, Massachusetts, Colorado, Maryland and Florida cannabis markets during 2017 and 2018 through its current users and relationships. After the eight initiatives passed on November 8, 2016 are implemented, the Company estimates there will be roughly 2,800 dispensaries operating in the regulated cannabis industry and the value of combining our two business will create an ongoing revenue stream which then should increase shareholder value.

MassRoots also released an updated corporate overview deck, accessible here. For more detailed information, please see MassRoots’ Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on July 5, 2017.

About MassRoots
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The company’s Apple iOS and Android mobile apps enable consumers to provide community-driven reviews of cannabis strains and products, enabling consumers to make educated cannabis purchasing decisions. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.

About Odava
Odava is one of the leading technology platforms providing compliance, point-of-sale, and supply chain management for the cannabis industry. Its team is made of technology-industry veterans with more than 35 years of experience in building Internet-scale infrastructure, including two co-founders from Urban Airship who were instrumental in raising over $60mm in venture capital funding and building the company to where it is today. For more information, please visit www.Odava.com.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Buz Investors Cannabis Oil Extraction Equipment Future Farm Technologies Inc. (the "Company" or "Future Farm") (OTCQB: FFRMF) (CSE: FFT.CN) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, has purchased

$FFRMF Acquires High Volume, State-of-the-Art Cannabis Oil Extraction Equipment

Future Farm Acquires High Volume, State-of-the-Art Cannabis Oil Extraction Equipment

Buz Investors Cannabis Oil Extraction Equipment Future Farm Technologies Inc. (the "Company" or "Future Farm") (OTCQB: FFRMF) (CSE: FFT.CN) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, has purchased

Buz Investors Cannabis Oil Extraction Equipment Future Farm Technologies Inc. (the “Company” or “Future Farm”) (OTCQB: FFRMF) (CSE: FFT.CN) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, has purchased a state-of-the-art extraction machine, for the manufacture of concentrated cannabis oil and purified distillate.

The equipment purchased is designed to rapidly manufacture premium cannabis oil, to supply the growing demand for cannabis concentrates, in the state of California. The equipment utilizes a closed-loop system, to produce high quality oil in a high throughput system with minimal maintenance and labor. The equipment is estimated to be delivered, installed and in full production within the next 90 days.

 



OTHER STORIES BUZ TRADERS FOLLOW

Cannabis Oil Extraction Equipment

Projected vendor recommendations and ROI:

  • Load Capacity per run = 20lb
  • Run Time = 1 hour (24 potential runs daily)
  • Oil yield = 10% on average
  • Estimated oil yield per run = 9080 grams
  • Estimated wholesale price per gram = $10-$20
  • Potential revenue per hour = 9080 x $10 = $9,080

“We believe this alcohol extraction machine is the best extraction equipment on the market today, which allows us to be able to process large amounts of cannabis flower into highly pure concentrates from day one,” says Bill Gildea, CEO of Future Farm. “This equipment will immediately allow for high-volume and highly pure extraction production. With this purchase, Future Farm is now formalizing the marketing plan to include its own brand, as well as offering contract manufacturer services for other brands and cultivators across the state of California.”

Cannabis concentrates and edibles are the largest and fastest growing segments of the cannabis market, which many experts believe will overtake cannabis whole flower sales by 2020. The market for cannabis concentrates is booming because they are used to make edibles, topical ointments, capsules and other packaged products that require a more professional extraction. As the recreational industry gets underway in California, many in the concentrates niche believe it’s going to continue to explode in popularity.

“We are excited to begin creating unique extraction products, that are very high in quality as defined through a full complement of technical laboratory analysis,” says John Sweeney, Future Farm’s COO. “We will make data driven decisions that guide us, in further refining our processes to maintain the very best cannabinoid, flavonoid and terpene profiles. The chosen method of extraction is safe, non-pressurized, reliable, and easy to use. The low temperatures and short residence times helps to preserve all of the essential oils, and the consistency of operations including temperature, vacuum, and feed rates make it an ideal solution for scaling up.”

On behalf of the Board,

Future FarmTechnologies Inc.

William Gildea, CEO & Chairman

About Future Farm

The Company’s business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA), for the global production of various types of plants. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generate yields up to 10 times greater per square foot of land. The contained system provides many other benefits including seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability.

The Company is also in the business of designing and distributing LED lighting solutions, utilizing the COB and MCOB technology. The Company is focused on delivering cost efficient lighting to North America, via advanced e-commerce sites the Company owns and operates. LEDCanada.com which caters to B2B customers is a supplier of the newest and highest demand LED solutions. The Company also owns and operates COBGrowlights.com, which caters to both large and small agriculture green houses and controlled cultivation centers.


Ebates Coupons and Cash Back



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Organigram Acquires Adjacent Property for Infused Products Manufacturing

$OGRMF Acquires Adjacent Property for Infused Products Manufacturing

a) Pos(r)--md Pos(r)--sm W(1/1)--sm W(1/4) W(1/1)--md ie-7_Mstart(-310px)" data-reactid="24">
r) Bxz(bb) Fl(end) Fl(n)--sm Fl(n)--md M(a)--sm M(a)--md Maw(340px) Maw(640px)--sm Maw(640px)--md P(20px) Pb(0)--md Pb(0)--sm W(1/1)" data-reactid="27">
a) W(a)--sm W(0) W(a)--md" data-reactid="28">
r) Start(-150px) Start(a)--sm Start(a)--md W(a)--sm W(300px) W(a)--md" data-reactid="29">

36px) Fz(25px)--sm Fz(32px) Mb(17px)--sm Mb(20px) Mb(30px)--lg Ff($ff-primary) Lts($lspacing-md) Fw($fweight) Fsm($fsmoothing) Fsmw($fsmoothing) Fsmm($fsmoothing) Wow(bw)" data-reactid="3">Organigram Acquires Adjacent Property for Infused Products Manufacturing

Organigram Acquires Adjacent Property for Infused Products Manufacturing

36px) Fz(25px)--sm Fz(32px) Mb(17px)--sm Mb(20px) Mb(30px)--lg Ff($ff-primary) Lts($lspacing-md) Fw($fweight) Fsm($fsmoothing) Fsmw($fsmoothing) Fsmm($fsmoothing) Wow(bw)" data-reactid="3">Organigram Acquires Adjacent Property Organigram Holdings Inc. (TSX VENTURE:OGI)(OGRMF) (the “Company”) is pleased to announce it has entered an agreement for the acquisition of additional lands and premises adjacent to its existing property in Moncton, New Brunswick for $600,000 in cash. Concurrent with the closing of the transaction, Organigram will consolidate the acquired 91 English Drive property with its existing ACMPR licensed facilities located at 35 English Drive.

bb) Mstart(0)--sm Mstart(0)--md Mstart(33.3%) P(20px) W(1/1)--sm W(1/1)--md ie-7_W(45%)" data-reactid="39">
r) M(a) Maw(600px) Maw(800px)--lg Mih(650px) Mih(0)--sm" data-reactid="40">
r) P(20px)--sm Pt(17px)--sm" data-reactid="2">
bw) Cl(start) Mb(20px) Ff($ff-secondary) Fz(15px) Lh(1.6)" data-reactid="4">

Organigram expects that edibles and infused products will be a major part of the future medical and recreational market for cannabis products. In anticipation of this transition in consumer demand, the Company intends to construct a purpose built infused products manufacturing facility on this newly acquired property. This facility will be in addition to the previously announced oils and extracts manufacturing infrastructure engineered and designed in collaboration with our partners in Colorado, TGS International.

Some of the most notable takeaways from the final Cannabis Legalization and Regulation Task Force report related specifically to cannabis edibles and derivatives. The report noted the expectation for edibles to have a broad market appeal and that they should be regulated at the federal level, drawing on the good production practices of the current cannabis for medical purposes system.

“Many of these observations and recommendations of the task force were derived from the experiences and regulations related to cannabis infused products in the more developed US states. Our joint venture partners from Colorado, TGS International, provide Organigram with invaluable insight from their experience as leaders in edibles manufacturing and retailing in these markets. We will be working closely with them and drawing on their insights as we establish a similar vertically integrated manufacturing platform for these products right here in Canada,” says Denis Arsenault, CEO of Organigram.

Under the terms of the agreement, Organigram will acquire the 2.6-acre property, subject to certain terms and conditions and will have until January 16th to conduct confirmatory due diligence. Closing of the transaction is expected to occur or before March 31, 2017.

Organigram also announces the appointment of Michael Tripp as Chief Legal Officer of the Company. Prior to commencing this role, Mr. Tripp engaged in private practice at a respected business law firms in Moncton and Toronto and as General Counsel and Secretary to a TSX-V listed company.

For more information, visit www.Organigram.ca

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Delphi Automotive (DLPH) Acquires Movimento

Delphi Automotive (DLPH) Acquires Movimento

Delphi Automotive (DLPH) Acquires Movimento

  • Buz Investors Delphi Automotive With software and services playing an increasingly critical role in all areas of the automotive industry, Delphi Automotive PLC (NYSE: DLPH) today announced it has acquired Movimento, a leading provider of Over-the-Air (OTA) software lifecycle and data management for the automotive sector.Movimento‘s advanced technology platform enables manufacturers to quickly and efficiently upgrade or fix software at all stages of a vehicle’s lifecycle.
  • Its OTA capabilities provide end consumers the ease and convenience of software updates, allowing new features and functionality to be added to their vehicles instantaneously, all the while reducing warranty and service costs for the vehicle manufacturer.

Delphi Automotive

Delphi Automotive <span data-recalc-dims=(DLPH) Acquires Movimento" width="300" height="182" srcset="https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/01/earns-auto-suppliersjpg-a5a699a90d5ee92a.resized.jpg?resize=300%2C182 300w, https://i1.wp.com/investorsbuz.com/wp-content/uploads/2017/01/earns-auto-suppliersjpg-a5a699a90d5ee92a.resized.jpg?w=640 640w" sizes="(max-width: 300px) 100vw, 300px" />

Delphi Automotive  “The acquisition of Movimento strengthens Delphi’s position as a leading end-to-end systems and software provider to the industry as vehicle connectivity becomes increasingly ubiquitous,” said Kevin Clark, president and CEO, Delphi Automotive. “Movimento’s over-the-air capability aligns perfectly with our Control-Tec acquisition last year, allowing Delphi to leverage big data to offer comprehensive product enhancements and service cost savings to our customers.”

Other Stories Buz Traders share

Delphi Automotive

Based in Michigan, Movimento supports customer operations globally and has its OTA and cloud technology development in Silicon Valley. It brings scalable vehicle software, engine control unit (ECU) programming, and OTA firmware and feature updates, all with advanced automotive cyber security validation functions to ensure a safe and secure software environment at all times. Movimento’s technology allows for a single gateway client to update a vehicle’s firmware, software and feature sets across multiple domains including infotainment, advanced safety and automated driving, and engine controls, allowing for simplified software design.

Combining Delphi’s system and software expertise with Control-Tec’s data analytics and Movimento’s OTA services will create an industry-leading, end-to-end connected vehicle platform for our customers that is able to manage vehicle performance data, consumer behavior data, maintenance, system upgrades, mobility services and 3rd party ancillary services.

“OTA capabilities are required for next-generation active safety, automated driving, and automated mobility on demand. Movimento’s technology will allow Delphi’s Centralized Sensing Localization and Planning (CSLP) solution to be continuously updated with innovations throughout its lifecycle,” added Clark.

Major Aerospace Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




MOTIF BIO ACQUIRES LATE STAGE ANTIBIOTIC AND ANNOUNCES PRE-IPO FINANCING

MOTIF BIO ACQUIRES LATE STAGE ANTIBIOTIC AND ANNOUNCES PRE-IPO FINANCING

MOTIF BIO ACQUIRES LATE STAGE ANTIBIOTIC AND ANNOUNCES PRE-IPO FINANCING

MOTIF BIO ACQUIRES LATE STAGE ANTIBIOTIC AND ANNOUNCES PRE-IPO FINANCING

Amphion Innovations, a developer of medical, life science, and technology businesses, is pleased to announce that Partner Company, Motif BioSciences Inc. (“Motif”), has entered into an agreement to merge with a private company that holds the intellectual property and world-wide rights to a clinical stage antibiotic designed to be effective against MRSA and multi-drug resistant bacteria (the “Acquisition”). Motif plans to start Phase III trials this year in two serious hospital-acquired infections.

Completion of the Acquisition is conditional inter-alia upon Motif completing an IPO before 31 March 2015.

Motif is a US-based drug discovery and development company focused on developing solutions for the antibiotic crisis. As of 31 December 2013, Amphion owned 32% of Motif.

Amphion is also pleased to announce that Motif has completed a pre-IPO AIM financing of £470,000 through the issue of convertible promissory notes (“Notes”). The Notes will automatically convert into Motif ordinary shares upon an AIM Admission on or before 31 March 2015. Should Motif not complete its proposed AIM listing by 31 March 2015, the Notes are convertible into Motif ordinary shares, Amphion ordinary shares, or repayable in cash over nine months at the option of each Note holder.

Amphion looks forward to updating the market on Motif’s proposed IPO in due course.

Richard Morgan, CEO of Amphion, said:

“Resistance to antibiotics is a major global public-health crisis. The most urgent need for novel antibiotics effective against multi-drug resistant bacteria is in the hospital setting where patients often succumb to serious, life-threatening infections that require immediate treatment with the best available antibiotic.

“The Acquisition of this clinical stage antibiotic is a game changer for Motif. As a result of change in the regulatory environment geared to encourage new antibiotics, we believe we have identified the right course for regulatory approval. Motif’s upcoming IPO will fund this exciting plan and we believe will generate and return value to both Motif and Amphion shareholders alike. ”

About Amphion Innovations plc

Amphion Innovations is a developer of medical, life science and technology businesses.

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.